Galibier Capital Management Ltd. Gsk PLC Transaction History

Galibier Capital Management Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$42.05 - $47.77 $8.68 Million - $9.86 Million	-206,363 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$40.23 - $47.74 $2.08 Million - $2.46 Million	-51,599 Reduced 20.0%	206,363 $8.99 Million
Q4 2021 Feb 08, 2022	SELL	$38.88 - $45.31 $9.91 Million - $11.5 Million	-254,853 Reduced 49.7%	257,962 $11.4 Million
Q2 2021 Jul 20, 2021	SELL	$36.52 - $41.46 $2.3 Million - $2.61 Million	-62,926 Reduced 10.93%	512,815 $20.4 Million
Q4 2020 Jan 19, 2021	BUY	$34.07 - $39.94 $4.26 Million - $4.99 Million	125,000 Added 27.73%	575,741 $21.2 Million
Q3 2020 Oct 26, 2020	BUY	$38.11 - $42.99 $17.2 Million - $19.4 Million	450,741 New	450,741 $17 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Galibier Capital Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Galibier Capital Management Ltd. with notifications on news.